|
1
|
Ikeda K, Ide S, Han W, Hayashida M, Uhl GR
and Sora I: How individual sensitivity to opiates can be predicted
by gene analyses. Trends Pharmacol Sci. 26:311–317. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Evans WE and McLeod HL: Pharmacogenomics -
Drug disposition, drug targets and side effects. N Engl J Med.
348:538–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weinshilboum R: Inheritance and drug
response. N Engl J Med. 348:529–537. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu
JH, Wang D, Li Z, He J, Zhong GP, Zhou G and Zhou HH: Effects of
genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine
pharmacokinetics after renal transplantation. Clin Exp Pharmacol
Physiol. 33:1093–1098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Walter C and Lötsch J: Meta-analysis of
the relevance of the OPRM1 118A>G genetic variant for pain
treatment. Pain. 146:270–275. 2009.PubMed/NCBI
|
|
6
|
Chou WY, Wang CH, Liu PH, Liu CC, Tseng CC
and Jawan B: Human opioid receptor A118G polymorphism affects
intravenous patient-controlled analgesia morphine consumption after
total abdominal hysterectomy. Anesthesiology. 105:334–337. 2006.
View Article : Google Scholar
|
|
7
|
Tan EC, Lim EC, Teo YY, Lim Y, Law HY and
Sia AT: Ethnicity and OPRM variant independently predict pain
perception and patient-controlled analgesia usage for
post-operative pain. Mol Pain. 5:322009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reyes-Gibby CC, Shete S, Rakvåg T, Bhat
SV, Skorpen F, Bruera E, Kaasa S and Klepstad P: Exploring joint
effects of genes and the clinical efficacy of morphine for cancer
pain: OPRM1 and COMT gene. Pain. 130:25–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ginosar Y, Davidson EM, Meroz Y, Blotnick
S, Shacham M and Caraco Y: Mu-opioid receptor (A118G)
single-nucleotide polymorphism affects alfentanil requirements for
extracorporeal shock wave lithotripsy: a
pharmacokinetic-pharmacodynamic study. Br J Anaesth. 103:420–427.
2009. View Article : Google Scholar
|
|
10
|
Klepstad P, Rakvåg TT, Kaasa S, Holthe M,
Dale O, Borchgrevink PC, Baar C, Vikan T, Krokan HE and Skorpen F:
The 118 A>G polymorphism in the human mu-opioid receptor gene
may increase morphine requirements in patients with pain caused by
malignant disease. Acta Anaesthesiol Scand. 48:1232–1239. 2004.
|
|
11
|
Zhang W, Chang YZ, Kan QC, Zhang LR, Lu H,
Chu QJ, Wang ZY, Li ZS and Zhang J: Association of human
micro-opioid receptor gene polymorphism A118G with fentanyl
analgesia consumption in Chinese gynaecological patients.
Anaesthesia. 65:130–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fukuda K, Hayashida M, Ide S, Saita N,
Kokita Y, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, Nagashima M, et
al: Association between OPRM1 gene polymorphisms and fentanyl
sensitivity in patients undergoing painful cosmetic surgery. Pain.
147:194–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fukuda K, Hayashida M, Ikeda K, Koukita Y,
Ichinohe T and Kaneko Y: Diversity of opioid requirements for
postoperative pain control following oral surgery - is it affected
by polymorphism of the μ-opioid receptor? Anesth Prog.
57:145–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hayashida M, Nagashima M, Satoh Y, Katoh
R, Tagami M, Ide S, Kasai S, Nishizawa D, Ogai Y, Hasegawa J, et
al: Analgesic requirements after major abdominal surgery are
associated with OPRM1 gene polymorphism genotype and haplotype.
Pharmacogenomics. 9:1605–1616. 2008. View Article : Google Scholar
|
|
15
|
Wong CA, McCarthy RJ, Blouin J and Landau
R: Observational study of the effect of mu-opioid receptor genetic
polymorphism on intrathecal opioid labor analgesia and
post-cesarean delivery analgesia. Int J Obstet Anesth. 19:246–253.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klepstad P, Fladvad T, Skorpen F, Bjordal
K, et al: Influence from genetic variability on opioid use for
cancer pain: a European genetic association study of 2294 cancer
pain patients. Pain. 152:1139–1145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Landau R, Kern C, Columb MO, Smiley RM and
Blouin JL: Genetic variability of the mu-opioid receptor influences
intrathecal fentanyl analgesia requirements in laboring women.
Pain. 30:5–14. 2008. View Article : Google Scholar
|
|
18
|
Kasai S: Pharmacogenomics of the human
μ-opioid receptor. Pharmacogenomics. 12:1305–1320. 2011.
View Article : Google Scholar
|
|
19
|
Speilberger CD, Gorsuch RL, Lushene R,
Vagg PR and Jacobs GA: Manual for the State-Trait Anxiety
Inventory. Consulting Psychologists Press; Palo Alto, California:
1983
|
|
20
|
Zung WW: A self-rating depression scale.
Arch Gen Psychiatry. 12:63–70. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bond C, LaForge KS, Tian M, Melia D, Zhang
S, Borg L, et al: Single-nucleotide polymorphism in the human mu
opioid receptor gene alters beta-endorphin binding and activity:
possible implications for opiate addiction. Proc Natl Acad Sci USA.
95:9608–9613. 1998. View Article : Google Scholar
|
|
22
|
Befort K, Filliol D, Decaillot FM,
Gaveriaux-Ruff C, Hoehe MR and Kieffer BL: A single nucleotide
polymorphic mutation in the human mu-opioid receptor severely
impairs receptor signaling. J Biol Chem. 276:3130–3137. 2001.
View Article : Google Scholar
|
|
23
|
Beyer A, Koch T, Schröder H, Schulz S and
Höllt V: Effect of the A118G polymorphism on binding affinity,
potency and agonist-mediated endocytosis, desensitization and
resensitization of the human mu-opioid receptor. J Neurochem.
89:553–560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mahmoud S, Thorsell A, Sommer WH, Heilig
M, Holgate JK, Bartlett SE, et al: Pharmacological consequence of
the A118G μ-opioid receptor polymorphism on morphine- and
fentanyl-mediated modulation of Ca2+ channels in
humanized mouse sensory neurons. Anesthesiology. 115:1054–1062.
2011.
|
|
25
|
Sia AT, Lim Y, Lim EC, Goh RW, Law HY,
Landau R, et al: A118G single nucleotide polymorphism of human
mu-opioid receptor gene influences pain perception and
patient-controlled intravenous morphine consumption after
intrathecal morphine for post-cesarean analgesia. Anesthesiology.
109:520–526. 2008. View Article : Google Scholar
|
|
26
|
Zhang W, Yuan JJ, Kan QC, Zhang LR, Chang
YZ and Wang ZY: Study of the OPRM1 A118G genetic polymorphism
associated with postoperative nausea and vomiting induced by
fentanyl intravenous analgesia. Minerva Anestesiol. 77:33–39.
2011.PubMed/NCBI
|
|
27
|
Walldén J, Lindberg G, Sandin M, Thörn SE
and Wattwil M: Effects of fentanyl on gastric myoelectrical
activity: a possible association with polymorphisms of the
mu-opioid receptor gene? Acta Anaesthesiol Scand. 52:708–715.
2008.PubMed/NCBI
|
|
28
|
Lin WQ, Cao LH, Zhong ZJ, Wen LL and Bai
XH: Postoperative analgesia with fentanyl combined with
flurbiprofen axetil following gynecologic surgery for turnor. Nan
Fang Yi Ke Da Xue Xue Bao. 29:313–315. 2009.(In Chinese).
|
